Proton pump inhibitors affect the gut microbiome

Articles citing Proton pump inhibitors affect the gut microbiome

Title / Author	Year
Extensive impact of non-antibiotic drugs on human gut bacteria L Maier, M Pruteanu, M Kuhn, G Zeller, A Telzerow, EE Anderson, ... Nature 555 (7698), 623-628	2018
European consensus conference on faecal microbiota transplantation in clinical practice G Cammarota, G Ianiro, H Tilg, M Rajilić-Stojanović, P Kump, R Satokari, ... Gut 66 (4), 569-580	2017
Human gut microbiome: hopes, threats and promises PD Cani Gut 67 (9), 1716-1725	2018
The effect of host genetics on the gut microbiome MJ Bonder, A Kurilshikov, EF Tigchelaar, Z Mujagic, F Imhann, AV Vila, ... Nature genetics 48 (11), 1407-1412	2016
The gut microbiome in atherosclerotic cardiovascular disease Z Jie, H Xia, SL Zhong, Q Feng, S Li, S Liang, H Zhong, Z Liu, Y Gao, ... Nature communications 8 (1), 1-12	2017
The evolution of the host microbiome as an ecosystem on a leash KR Foster, J Schluter, KZ Coyte, S Rakoff-Nahoum Nature 548 (7665), 43-51	2017
Interplay of host genetics and gut microbiota underlying the onset and clinical presentation of inflammatory bowel disease F Imhann, AV Vila, MJ Bonder, J Fu, D Gevers, MC Visschedijk, ... Gut 67 (1), 108-119	2018
Optimizing methods and dodging pitfalls in microbiome research D Kim, CE Hofstaedter, C Zhao, L Mattei, C Tanes, E Clarke, A Lauder, ... Microbiome 5 (1), 1-14	2017
Gut microbiome interactions with drug metabolism, efficacy, and toxicity ID Wilson, JK Nicholson Translational Research 179, 204-222	2017
The human gut microbiome: from association to modulation TSB Schmidt, J Raes, P Bork Cell 172 (6), 1198-1215	2018
Machine learning meta-analysis of large metagenomic datasets: tools and biological insights E Pasolli, DT Truong, F Malik, L Waldron, N Segata PLoS computational biology 12 (7), e1004977	2016
Systematic review with meta‐analysis: the efficacy of probiotics in inflammatory bowel disease Y Derwa, DJ Gracie, PJ Hamlin, AC Ford Alimentary pharmacology & therapeutics 46 (4), 389-400	2017
Gut microbiota associations with common diseases and prescription medications in a population-based cohort MA Jackson, S Verdi, ME Maxan, CM Shin, J Zierer, RCE Bowyer, ... Nature communications 9 (1), 1-8	2018
Proton pump inhibitors increase risk for hepatic encephalopathy in patients with cirrhosis in a population study CF Tsai, MH Chen, YP Wang, CJ Chu, YH Huang, HC Lin, MC Hou, ... Gastroenterology 152 (1), 134-141	2017
Development of a gut microbe–targeted nonlethal therapeutic to inhibit thrombosis potential AB Roberts, X Gu, JA Buffa, AG Hurd, Z Wang, W Zhu, N Gupta, SM Skye, ... Nature medicine 24 (9), 1407-1417	2018
Factors influencing the gut microbiota, inflammation, and type 2 diabetes L Wen, A Duffy The Journal of nutrition 147 (7), 1468S-1475S	2017
The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridium difficile infection and other potential indications: joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines BH Mullish, MN Quraishi, JP Segal, VL McCune, M Baxter, GL Marsden, ... Gut 67 (11), 1920-1941	2018
Host genetics and gut microbiome: challenges and perspectives A Kurilshikov, C Wijmenga, J Fu, A Zhernakova Trends in immunology 38 (9), 633-647	2017
Proton pump inhibitors: risks of long‐term use LH Eusebi, S Rabitti, ML Artesiani, D Gelli, M Montagnani, RM Zagari, ... Journal of gastroenterology and hepatology 32 (7), 1295-1302	2017
Maintenance therapy with proton pump inhibitors and risk of gastric cancer: a nationwide population-based cohort study in Sweden N Brusselaers, K Wahlin, L Engstrand, J Lagergren BMJ open 7 (10)	2017

1 - 20

Dates and citation counts are estimated and are determined automatically by a computer program.